000			02220nam a22004695i 4500
001			978-3-7091-1331-8
003			DE-He213
005			20140220082925.0
007			cr nn 008mamaa
008			130326s2013 au | s |||| 0|eng d
020			_a9783709113318 _9978-3-7091-1331-8
024	7		_a10.1007/978-3-7091-1331-8 _2doi
050		4	_aRC627.5-632
072		7	_aMFGM _2bicssc
072		7	_aMED027000 _2bisacsh
082	0	4	_a616.39 _223
100	1		_aBeck-Nielsen, Henning. _eeditor.
245	1	4	_aThe Metabolic Syndrome _h[electronic resource] : _bPharmacology and Clinical Aspects / _cedited by Henning Beck-Nielsen.
264		1	_aVienna : _bSpringer Vienna : _bImprint: Springer, _c2013.
300			_aXI, 229 p. 33 illus., 26 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
520			_aMetabolic syndrome is a common syndrome affecting about 20% of the adult population in Europe, and the prevalence is likely similar in other industrialised countries worldwide. It is mainly caused by the western lifestyle, which tends to produce abdominal obesity, but a genetic predisposition also plays a part. This syndrome, which is linked to leisure lifestyles and overeating/obesity, can develop into type 2 diabetes, cardiovascular disease and cancer. Therefore, proper treatment and prevention are essential. This book discusses lifestyle intervention and treatment, specifically with pharmacological compounds, in order to formulate a strategy for treating the metabolic syndrome in daily practice.
650		0	_aMedicine.
650		0	_aToxicology.
650		0	_aDiabetes.
650		0	_aEndocrinology.
650		0	_aMetabolic diseases.
650	1	4	_aMedicine & Public Health.
650	2	4	_aMetabolic Diseases.
650	2	4	_aPharmacology/Toxicology.
650	2	4	_aEndocrinology.
650	2	4	_aDiabetes.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783709113301
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-7091-1331-8
912			_aZDB-2-SME
999			_c98970 _d98970